Biofrontera Ag (BFAGY)

Biofrontera Ag Financial Statements


Biofrontera Ag Financial Overview

Biofrontera Ag's market cap is currently ―. The company's EPS TTM is $0.613; its P/E ratio is 4.01; Biofrontera Ag is scheduled to report earnings on August 18, 2022, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 20Dec 19Dec 18Dec 17Dec 16
Income Statement
Total Revenue€ 30.35M€ 31.27M€ 21.11M€ 12.03M€ 6.13M
Gross Profit€ 26.81M€ 26.39M€ 16.66M€ 10.31M€ 4.48M
EBIT€ -9.62M€ -2.07M€ -17.48M€ -14.97M€ -9.37M
EBITDA€ -4.28M€ 1.09M€ -16.73M€ -14.09M€ -8.54M
Net Income Common Stockholders€ -13.02M€ -7.36M€ -8.88M€ -15.25M€ -10.58M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments€ 11.65M€ 12.20M€ 15.80M€ 17.08M€ 20.25M
Total Assets€ 56.39M€ 58.36M€ 39.13M€ 19.85M€ 23.88M
Total Debt€ 3.76M€ 12.53M€ 13.74M€ 23.25M€ 23.95M
Net Debt€ -7.89M€ 330.00K€ -2.06M€ 6.17M€ 3.70M
Total Liabilities€ 49.02M€ 48.41M€ 22.78M€ 16.47M€ 8.04M
Stockholders Equity€ 3.38M€ 7.38M€ 9.95M€ 15.84M€ 16.36M
Cash Flow
Free Cash Flow€ -3.62M€ -34.75M€ -13.95M€ -13.52M€ -10.74M
Operating Cash Flow€ -2.85M€ -32.89M€ -13.43M€ -13.12M€ -10.26M
Investing Cash Flow€ 2.87M€ 21.05M€ -511.00K€ -375.00K€ -455.00K
Financing Cash Flow€ 5.95M€ 3.46M€ 22.27M€ 9.45M€ 21.88M
Currency in EUR

Biofrontera Ag Earnings and Revenue History

Biofrontera Ag Debt to Assets

Biofrontera Ag Cash Flow

Biofrontera Ag Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis